Differential action of TIGIT on islet and peripheral nerve autoimmunity in the NOD mouse

Author:

Bécourt Chantal,Luce Sandrine,Rogner Ute C.ORCID,Boitard Christian

Abstract

SummaryWe previously demonstrated that the abrogation of the ICOS pathway prevents type 1 diabetes development in the Non Obese Diabetic (NOD) mouse, but results in a CD4+T-cell dependent autoimmune neuromyopathy in aged mice. Pancreatic islet infiltrates in conventional NOD mice and neuromuscular infiltrates inIcosl-/-NOD mice have in common that they exhibit a strong enrichment in CD4+TIGIT+T-cells, whilst TIGIT expression in the peripheral CD4+T-cells is limited to the CD4+FoxP3+T-cell population.When deletingTigiton the NOD background, diabetes incidence was found increased. Peripheral CD4+CD226+effector T-cells exhibited an increased frequency of IL-17 producing CD4+CD226+RORgt+T-cellsversusa decreased frequency of IFNγ-producing CD4+CD226+Tbet+T-cells.ICOS is expressed in both CD4+FoxP3+and CD4+CD226+splenic T-cell subsets.Icosldeletion leads to a decrease of CD4+FoxP3+cells, with decrease of PD1 but increase of ICOS and CCRX3. Also in theIcosl-/-model, CD4+CD226+T-cells are decreased byTigitdeletion, and showed an increase of CD4+CD226+RORgt+T-cells and a decrease of CD4+CD226+Tbet+T-cells.However, deletion ofTigitin agedIcosl-/-NOD mice population did not increase the incidence of the autoimmune neuromyopathy observed inIcosl-/-NOD mice. Interestingly, the upregulation of CD4+CD226+RORgt+T-cells was partly rescued.We conclude from our study that bothIcoslandTigitdeletions on the NOD background lead to a shift between the ratio of IFNγ and IL-17-producing CD4+CD226+effector cells. The ICOS-dependent neuromyopathy development remains dominant and is not further altered in the absence of TIGIT.

Publisher

Cold Spring Harbor Laboratory

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3